Amy J. Hulme

Amy J. Hulme

Auto-generated profile, based on publicly available information

Amy J. Hulme

Molecular Horizons, School of Medical and Indigenous Health Sciences, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
PLPei Y. Liu
Pei Y. Liu
ATAndrew E. Tee
Andrew E. Tee
GMGiorgio Milazzo
Giorgio Milazzo
KHKatherine M. Hannan
Katherine M. Hannan
JMJesper Maag
Jesper Maag
TLTao Liu
Tao Liu
The majority of patients with neuroblastoma due to MYCN oncogene amplification and consequent N-Myc oncoprotein over-expression die of the disease. Here our analyses of RNA sequencing data identify the long noncoding RNA lncNB1 as one of the transcripts most over-expressed in MYCN-amplified, compared with MYCN-non-amplified, human neuroblastoma cells and also the most over-expressed in neuroblastoma compared with all other cancers. lncNB1 binds to the ribosomal protein RPL35 to enhance E2F1 protein synthesis, leading to DEPDC1B gene transcription. The GTPase-activating protein DEPDC1B induces ERK protein phosphorylation and N-Myc protein stabilization. Importantly, lncNB1 knockdown abolishes neuroblastoma cell clonogenic capacity in vitro and leads to neuroblastoma tumor regression in mice, while high levels of lncNB1 and RPL35 in human neuroblastoma tissues predict poor patient prognosis. This study therefore identifies lncNB1 and its binding protein RPL35 as key factors for promoting E2F1 protein synthesis, N-Myc protein stability and N-Myc-driven oncogenesis, and as therapeutic targets.

1 March 2024 in Science
Verified
Journal Article
Closed access
SCSampurna Chakrabarti
Sampurna Chakrabarti
JKJasmin D. Klich
Jasmin D. Klich
MKMohammed A. Khallaf
Mohammed A. Khallaf
AHAmy J. Hulme
Amy J. Hulme
OSOscar Sánchez-Carranza
Oscar Sánchez-Carranza
GLGary R. Lewin
Gary R. Lewin
Touch perception is enabled by mechanically activated ion channels, the opening of which excites cutaneous sensory endings to initiate sensation. In this study, we identify ELKIN1 as an ion channel likely gated by mechanical force, necessary for normal touch sensitivity in mice. Touch insensitivity in Elkin1 −/− mice was caused by a loss of mechanically activated currents (MA currents) in around half of all sensory neurons activated by light touch (low-threshold mechanoreceptors). Reintroduction of Elkin1 into sensory neurons from Elkin1 −/− mice restored MA currents. Additionally, small interfering RNA–mediated knockdown of ELKIN1 from induced human sensory neurons substantially reduced indentation-induced MA currents, supporting a conserved role for ELKIN1 in human touch. Our data identify ELKIN1 as a core component of touch transduction in mice and potentially in humans.

26 January 2021 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
VPVina Putra
Vina Putra
AHAmy J. Hulme
Amy J. Hulme
ATAndrew E. Tee
Andrew E. Tee
JSJane Q.J. Sun
Jane Q.J. Sun
BABernard Atmadibrata
Bernard Atmadibrata
PLPei Y. Liu
Pei Y. Liu
Approximately 25% of human neuroblastoma is caused by amplification of the MYCN oncogene, which leads to overexpression of N‐Myc oncoprotein. The survival rate for this patient subtype is <50%. Here, we show that N‐Myc protein bound to the DEAD‐box RNA helicase DDX21 gene promoter and upregulated DDX21 mRNA and protein expression. Genome‐wide differential gene expression studies identified centrosomal protein CEP55 as one of the genes most dramatically downregulated after DDX21 knockdown in MYCN‐amplified neuroblastoma cells. Knocking down DDX21 or CEP55 reduced neuroblastoma cell cytoskeleton stability and cell proliferation and all but abolished clonogenic capacity. Importantly, DDX21 knockdown initially induced tumor regression in neuroblastoma‐bearing mice and suppressed tumor progression. In human neuroblastoma tissues, a high level of DDX21 expression correlated with a high level of N‐Myc expression and with CEP55 expression, and independently predicted poor patient prognosis. Taken together, our data show that DDX21 induces CEP55 expression, MYCN‐amplified neuroblastoma cell proliferation, and tumorigenesis, and that DDX21 and CEP55 are valid therapeutic targets for the treatment of MYCN‐amplified neuroblastoma.

28 December 2018 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MEMartin Engel
Martin Engel
YGYi Sing Gee
Yi Sing Gee
DCDale Cross
Dale Cross
AMAlan Maccarone
Alan Maccarone
BHBenjamin Heng
Benjamin Heng
LOLezanne Ooi
Lezanne Ooi
Targeting epigenetic mechanisms has shown promise against several cancers but has so far been unsuccessful against glioblastoma (GBM). Altered histone 3 lysine 4 methylation and increased lysine‐specific histone demethylase 1A (LSD1) expression in GBM tumours nonetheless suggest that epigenetic mechanisms are involved in GBM. We engineered a dual‐action prodrug, which is activated by the high hydrogen peroxide levels associated with GBM cells. This quinone methide phenylaminecyclopropane prodrug releases the LSD1 inhibitor 2‐phenylcyclopropylamine with the glutathione scavenger para‐quinone methide to trigger apoptosis in GBM cells. Quinone methide phenylaminocyclopropane impaired GBM cell behaviours in two‐dimensional and three‐dimensional assays, and triggered cell apoptosis in several primary and immortal GBM cell cultures. These results support our double‐hit hypothesis of potentially targeting LSD1 and quenching glutathione, in order to impair and kill GBM cells but not healthy astrocytes. Our data suggest this strategy is effective at selectively targeting GBM and potentially other types of cancers.Open science badges: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/. image

13 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSimon Maksour
Simon Maksour
NNNeville S Ng
Neville S Ng
AHAmy J. Hulme
Amy J. Hulme
SMSara Miellet
Sara Miellet
MEMartin Engel
Martin Engel
MDMirella Dottori
Mirella Dottori
Repressor element-1 silencing transcription factor (REST) is a transcriptional repressor involved in neurodevelopment and neuroprotection. REST forms a complex with the REST corepressors, CoREST1, CoREST2, or CoREST3 (encoded by RCOR1 , RCOR2 , and RCOR3 , respectively). Emerging evidence suggests that the CoREST family can target unique genes independently of REST, in various neural and glial cell types during different developmental stages. However, there is limited knowledge regarding the expression and function of the CoREST family in human neurodevelopment. To address this gap, we employed 2D and 3D human pluripotent stem cell (hPSC) models to investigate REST and RCOR gene expression levels. Our study revealed a significant increase in RCOR3 expression in glutamatergic cortical and GABAergic ventral forebrain neurons, as well as mature functional NGN2-induced neurons. Additionally, a simplified astrocyte transdifferentiation protocol resulted in a significant decrease in RCOR2 expression following differentiation. REST expression was notably reduced in mature neurons and cerebral organoids, along with RCOR2 in the latter. In summary, our findings provide the first insights into the cell-type-specific expression patterns of RCOR genes in human neuronal and glial differentiation. Specifically, RCOR3 expression increases in neurons, while RCOR2 levels decrease in astrocytes. The dynamic expression patterns of REST and RCOR genes during hPSC neuronal and glial differentiation underscore the potential distinct roles played by REST and CoREST proteins in regulating the development of these cell types in humans. Graphical Highlights: REST and RCOR genes display cell-type specific expression patterns in neural cells RCOR3 (encodes CoREST3) is upregulated during neuronal and astrocyte differentiation RCOR2 (encodes CoREST2) is downregulated during differentiation of astrocytes Evidence of potential cell-type specific functions of the CoREST family

9 April 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
ECEwa Czuba-Wojnilowicz
Ewa Czuba-Wojnilowicz
SVSerena Viventi
Serena Viventi
SHSara Howden
Sara Howden
SMSimon Maksour
Simon Maksour
AHAmy E. Hulme
Amy E. Hulme
FCFrank Caruso
Frank Caruso
Increasing frataxin protein levels through gene therapy is envisaged to improve therapeutic outcomes for patients with Friedreich's ataxia (FRDA). A non-viral strategy that uses submicrometer-sized multilayered particles to deliver frataxin-encoding plasmid DNA affords up to 27 000-fold increase in frataxin gene expression within 2 days in vitro in a stem cell-derived neuronal model of FRDA.